Cardiotoxicity After Synthetic Cathinone Use; Two Cases, A Case Series and Scoping Review
K L Groenewegen1, F M J Gresnigt2,3, J J Nugteren-van Lonkhuyzen4
1Resident Cardiology, Heartcenter, OLVG Amsterdam, Oosterpark 9, 1091 AC, Amsterdam, The Netherlands.
Cardiovascular Toxicology
|February 27, 2024
Summary
Synthetic cathinone use can lead to serious heart problems, including heart attacks and dangerous arrhythmias. This study highlights the cardiotoxicity risks associated with these drugs, emphasizing the need for awareness among healthcare providers.
Area of Science:
- Cardiology
- Toxicology
- Pharmacology
Background:
- The cardiotoxic effects of synthetic cathinones are not well understood.
- This study investigates synthetic cathinone-associated cardiotoxicity through case reports and a literature review.
Observation:
- Two cases presented with myocardial infarction and ventricular fibrillation after synthetic cathinone ingestion.
- A retrospective analysis of 222 poisonings revealed tachycardia, hypertension, and chest pain, primarily linked to 3-methylmethcathinone.
- A literature review identified 40 cases of cardiac arrest, myocardial infarction, and arrhythmias associated with ten different synthetic cathinones.
Findings:
- Synthetic cathinones are associated with a range of severe cardiac complications.
- Cardiac arrest, myocardial infarction, and life-threatening arrhythmias are significant risks.
Implications:
- Clinicians should inquire about recreational drug use in patients with cardiac symptoms.
- Increased awareness of synthetic cathinone cardiotoxicity is crucial for patient management and public health.
- Further research is needed to fully elucidate the mechanisms of synthetic cathinone cardiotoxicity.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
588
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
744
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
744
01:29Stimulants
195
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
195
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
996
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
996
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K